The treatment armamentarium of atopic dermatitis (AD) includes pharmaceuticals like emollients, topical corticosteroids, and topical calcineurin inhibitors. Recently available, medical devices are a newer class of topical, non-steroidal, semi-solid formulation for the treatment of AD and touted to possess emollient, anti-inflammatory, and anti-pruritic properties. To determine the role of medical devices in flare and remission management in AD, a panel of local experts from the field of dermatology, paediatric dermatology, and allergy convened to review the available evidence and highlights of the meeting are reported here.
Hair loss is a common problem for both men and women. Despite the various treatments available, hair loss remains a difficult condition to treat in most people. To gain better insights into the science behind hair loss, an interview was conducted recently with Dr Jia-Wei Liu, member of the European Hair Research Society and Vice President of Research and Development at Legacy Healthcare, Switzerland. The interview focused on hair loss and its management with CG 210TM, a novel botanical hair and scalp essence.
There is a marked difference in the thickness of the granular layer between palmar psoriasis and hand eczema, and this may be helpful in differentiating between the two skin conditions, according to a recent study.
A 10-day course of clindamycin or trimethoprim-sulfamethoxazole after incision and drainage of a small abscess is associated with a better clinical cure rate than incision and drainage alone, according to a recent study.